We now know how many jobs come under the ax at Novartis, and it is not small.
The pharmaceutical giant confirms a report from the Swiss newspaper Day indicator that it is cutting 8,000 jobs from its 108,000 global employees. A large segment will hit right at the company’s headquarters in Basel, as CEO Vas Narasimhan will lay off 1,400 of a little more than 11,000 jobs in Switzerland.
The first phase of the work is almost complete, the company says in another message Endpoints News. Now it’s over to phase two. In the statement, Novartis says:
Continue reading Endpoints with a free subscription
Unlock this story instantly and join over 1[ads1]44,800 biopharmaceutical professionals who read Endpoints daily – and it’s free.